A randomized clinical trial has found that the COVID-19 vaccine produced by Novavax Inc. is “safe, immunogenic, and efficacious in preventing” the coronavirus in adolescents.
Source: washingtontimes.com
Please follow and like us:
A randomized clinical trial has found that the COVID-19 vaccine produced by Novavax Inc. is “safe, immunogenic, and efficacious in preventing” the coronavirus in adolescents.
Source: washingtontimes.com